osimertinib
astrazeneca
['lung', 'tagrisso', 'astrazeneca']
asco: to adjuvant tagrisso doubters astrazeneca's egfr med extends survival in early lung cancer 
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.